Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Revenue

Extrawell Pharmaceutical Holdings had revenue of 28.01M HKD in the half year ending September 30, 2025, a decrease of -7.08%. This brings the company's revenue in the last twelve months to 52.65M, down -11.41% year-over-year. In the fiscal year ending March 31, 2025, Extrawell Pharmaceutical Holdings had annual revenue of 55.43M, down -6.21%.

• Revenue (ttm): 52.65M
• Revenue Growth: -11.41%
• P/S Ratio: 3.92
• Revenue / Employee: 326.99K
• Employees: 161
• Market Cap: 206.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	55.43M	-3.67M	-6.21%
Mar 31, 2024	59.10M	-13.48M	-18.57%
Mar 31, 2023	72.58M	-1.35M	-1.82%
Mar 31, 2022	73.93M	-4.88M	-6.19%
Mar 31, 2021	78.80M	1.22M	1.57%